Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advance Non-small Cell Lung Cancer”

13 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 13 of 13 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT06918782
What this trial is testing

Real-world Experience With Combination Chemotherapy and Osimertinib in Poor Prognostic Group of Metastatic EGFR-mutated Lung Adenocarcinoma

Who this might be right for
Lung Cancer (NSCLC)
The University of Hong Kong 47
Testing effectiveness (Phase 2)Looking for participantsNCT07610798
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-8989 in Patients With Advanced Solid Tumors Harboring KRAS G12D Mutations

Who this might be right for
Advance Solid TumorsColon and Rectal CancerNon - Small Cell Lung Cancer NSCLC+4 more
Shenzhen Ionova Life Sciences Co., Ltd. 178
Testing effectiveness (Phase 2)Study completedNCT00137839
What this trial is testing

Erlotinib in Women With Previously Untreated Adenocarcinoma of the Lung

Who this might be right for
AdenocarcinomaNon-small Cell Lung Cancer
Pasi A. Janne, MD, PhD 84
Testing effectiveness (Phase 2)Study completedNCT05756153
What this trial is testing

GFH925 in Combination With Cetuximab in Previously Untreated Advanced NSCLC Harboring KRAS G12C Mutation

Who this might be right for
Advance Non-small Cell Lung Cancer
Genfleet Therapeutics (Shanghai) Inc. 47
Early research (Phase 1)WithdrawnNCT01562301
What this trial is testing

Sublingual Anvirzel in Advance Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Chemotherapeutic Agent ToxicityLung Cancer
M.D. Anderson Cancer Center
Early research (Phase 1)Ended earlyNCT05621525
What this trial is testing

Phase I Study of the BBP-398 in Patients With Advance Solid Tumors

Who this might be right for
Advanced Solid TumorAdvanced or Metastatic Non-small Cell Lung Cancer
LianBio LLC 7
Testing effectiveness (Phase 2)Study completedNCT01137968
What this trial is testing

Imetelstat as Maintenance Therapy After Initial Induction Chemotherapy in Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer
Geron Corporation 116
Not applicableActive Not RecruitingNCT06616909
What this trial is testing

Advance Care Planning Impact on the Consistency of Older Adults With Lung Cancer and Their Potential Surrogates Regarding Life-Sustaining Treatment Preferences

Who this might be right for
Advanced Care Planning (ACP)ELDERLY PEOPLELung Cancer (NSCLC)
National Taiwan University Hospital 120
Not applicableStudy completedNCT01279408
What this trial is testing

Observing Patients With Palliative Asymptomatic Centrally Located Advanced Non-small Cell Lung Carcinoma (NSCLC)

Who this might be right for
Non-small Cell Lung Carcinoma
University Health Network, Toronto 46
Testing effectiveness (Phase 2)Study completedNCT03037385
What this trial is testing

Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors

Who this might be right for
RET-altered Non Small Cell Lung CancerMedullary Thyroid CancerRET-altered Papillary Thyroid Cancer+37 more
Hoffmann-La Roche 590
Early research (Phase 1)Looking for participantsNCT07229313
What this trial is testing

KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Advance Solid Tumors
Kivu Bioscience Inc. 76
Post-approval studies (Phase 4)Study completedNCT02151149
What this trial is testing

Safety and Efficacy Study of Abraxane in Combination With Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Who this might be right for
Non-Small Cell Lung CancerCarcinomaSquamous Cell Carcinoma+3 more
Celgene 143
Testing effectiveness (Phase 2)Ended earlyNCT04856176
What this trial is testing

Sargramostim Plus Pembrolizumab with or Without Pemetrexed in Patients with Advance Non-small Cell Lung Cancer After Completion of Chemoimmunotherapy

Who this might be right for
Advanced Lung Non-Small Cell CarcinomaNon-Small Cell Carcinoma of Lung, TNM Stage 4
Tufts Medical Center 5